4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT01626222 · COMPLETED
Trial details
- NCT number
- NCT01626222
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2013-11-01
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.